Quantitative assessment of dna methylation for the detection of cervical and endometrial adenocarcinomas in liquid-based cytology specimens

Analytical and Quantitative Cytology and Histology

Volumn 34, Issue 4, 2012, Pages 195-203

  Kim, Ga Eon ^a   Kweon, Sun Seog ^b   Lee, Ji Shin ^b   Lee, Jae Hyuk ^b   Nam, Jong Hee ^b   Choi, Chan ^b  

^a Seonam University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

Adenocarcinoma; Cervix; Cytology; Endometrium; Methylation; Quantitation

Indexed keywords

APC; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RETINOIC ACID RECEPTOR BETA; TRANSCRIPTION FACTOR TWIST; DIAGNOSTIC AGENT; RASSF1 PROTEIN, HUMAN; RETINOIC ACID RECEPTOR; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; CANCER CYTODIAGNOSIS; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA METHYLATION; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CYTOLOGY; FEASIBILITY STUDY; FEMALE; HIGH IN NORMAL 1 GENE; HUMAN; HUMAN TISSUE; LIQUID CULTURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; ADENOCARCINOMA; AGED; AREA UNDER THE CURVE; CANCER GRADING; CANCER STAGING; CYTODIAGNOSIS; CYTOLOGY; ENDOMETRIUM TUMOR; GENETICS; IMMUNOHISTOCHEMISTRY; METHODOLOGY; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR GENE; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADULT; AGED; AREA UNDER CURVE; CYTODIAGNOSIS; CYTOLOGICAL TECHNIQUES; DNA METHYLATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, APC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; NEOPLASM GRADING; NEOPLASM STAGING; RECEPTORS, RETINOIC ACID; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84868255624     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Shin HR, Jung KW, Won YJ, Kong HJ, Yim SH, Sung J, Seo SW, Kim KY, Lee SY, Kong IS, Hwang IK, Lee CW, Woo ZH, Lee TY, Choi JS, Yoo CI, Bae JM, Yoo KY. National cancer incidence for the year 2002 in Korea. Cancer Res Treat 2007; 39:139-149
2. Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S. Cervical adenocarcinoma and squamous cell carcinoma inci-dence trends among white women and black women in the United States for 1976-2000. Cancer 2004;100:1035-1044
3. Gurpid E. Endometrial cancer: Biochemical and clinical correlates. J Natl Cancer Inst 1991;83:405-416
4. Fadare O, Zheng W. Endometrial Glandular Dysplasia (EmGD): Morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers. Diagn Pathol 2008;3:6
5. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30
6. Kim SJ, An HJ, Kim HJ, Jungs HM, Lee S, Ko JJ, Kim IH, Sakuragi N, Kim JK. Imup-1 and imup-2 overexpression in endometrial carcinoma in Korean and Japanese populations. Anticancer Res 2008;28:865-871
7. Koss L. The Papanicolaou test for cervical cancer detection: A triumph and a tragedy. JAMA 1989;261:737-743
8. Moriarty AT, Wilbur D. Those gland problems in cervical cytology: Faith or fact? Observations from the Bethesda 2001 terminology conference. Diagn Cytopathol 2003;28:171-174
9. Guidos BJ, Selvaggi SM. Detection of endometrial adenocarcinoma with the ThinPrep Pap test. Diagn Cytopathol 2000; 23:260-265
10. Schorge JO, Hossein Saboorian M, Hynan L, Ashfaq R. Thin-Prep detection of cervical and endometrial adenocarcinoma: A retrospective cohort study. Cancer 2002;96:338-343
11. Kim HS, Underwood D. Adenocarcinomas in the cervicovaginal Papanicolaou smear: Analysis of a 12-year experience. Diagn Cytopathol 1991;7:119-124
12. Kang S, Kim JW, Kang GH, Lee S, Park NH, Song YS, Park SY, Kang SB, Lee HP. Comparison of DNA hypermethylation patterns in different types of uterine cancer: Cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma. Int J Cancer 2006;118:2168-2171
13. Lin YW, Chung MT, Lai HC, De Yan M, Shih YL, Chang CC, Yu MH. Methylation analysis of SFRP genes family in cervical adenocarcinoma. J Cancer Res Clin Oncol 2009;135:1665-1674
14. Reesink-Peters N, Wisman GB, Jeronimo C, Tokumaru CY, Cohen Y, Dong SM, Klip HG, Buikema HJ, Suurmeijer AJ, Hollema H, Boezen HM, Sidransky D, van der Zee AG. Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: A feasibility study. Mol Cancer Res 2004;2:289-295
15. Lai HC, Lin YW, Huang TH, Yan P, Huang RL, Wang HC, Liu J, Chan MW, Chu TY, Sun CA, Chang CC, Yu MH. Identification of novel DNA methylation markers in cervical cancer. Int J Cancer 2008;123:161-167
16. Apostolidou S, Hadwin R, Burnell M, Jones A, Baff D, Pyndiah N, Mould T, Jacobs IJ, Beddows S, Kocjan G, Widschwendter M. DNA methylation analysis in liquid-based cytology for cervical cancer screening. Int J Cancer 2009;125: 2995-3002
17. Kim JH, Choi YD, Lee JS, Lee JH, Nam JH, Choi C. Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens. Gynecol Oncol 2010;116:990-104
18. Fiegl H, Gattringer C, Widschwendter A, Schneitter A, Ramoni A, Sarlay D, Gaugg I, Goebel G, Muller HM, Mueller-Holzner E, Marth C, Widschwendter M. Methylated DNA collected by tampons: A new tool to detect endometrial cancer. Cancer Epidemiol Biomarkers Prev 2004;13:882-888
19. Wisman GB, Nijhuis ER, Hoque MO, Reesink-Peters N, Koning AJ, Volders HH, Buikema HJ, Boezen HM, Hollema H, Schuuring E, Sidransky D, van der Zee AG. Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer 2006;119:1908-1914
20. Cottrell SE, Laird PW. Sensitive detection of DNA methylation. Ann N Y Acad Sci 2003;983:120-130
21. Fackler MJ, Malone K, Zhang Z, Schilling E, Garrett-Mayer E, Swift-Scanlan T, Lange J, Nayar R, Davidson NE, Khan SA, Sukumar S. Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res 2006;12:3306-3310
22. Kim JH, Choi YD, Lee JS, Lee JH, Nam JH, Choi C, Kweon SS, Fackler MJ, Sukumar S. Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquidbased cytology specimens. Virchows Arch 2010;457:35-42
23. Swift-Scanlan T, Blackford A, Argani P, Sukumar S, Fackler MJ. Two-color quantitative multiplex methylation-specific PCR. Biotechniques 2006;40:210-S219
24. Lee JS, Fackler MJ, Lee JH, Choi C, Park MH, Yoon JH, Zhang Z, Sukumar S. Basal-like breast cancer displays distinct patterns of promoter methylation. Cancer Biol Ther 2010;9: 1017-1024
25. Lee HS, Kim KM, Kim SM, Choi YD, Nam JH, Park CS, Choi HS. Human papillomavirus genotyping using HPV DNA chip analysis in Korean women. Int J Gynecol Cancer 2007; 17:497-501
26. Kang S, Kim JW, Kang GH, Lee S, Park NH, Song YS, Park SY, Kang SB, Lee HP. Comparison of DNA hypermethylation patterns in different types of uterine cancer: Cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma. Int J Cancer 2006;118:2168-2171
27. Simsir A, Hwang S, Cangiarella J, Elgert P, Levine P, Sheffield MV, Roberson J, Talley L, Chhieng DC. Glandular cell atypia on Papanicolaou smears: Interobserver variability in the diagnosis and prediction of cell of origin. Cancer 2003;99:323-330